Johnson & Johnson (JNJ) Tops Q2 EPS by 9c, Beats on Revenue; Offers Strong FY25 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $276.32 --0%
Financial Fact:
Research and development expense: 2.18B
Today's EPS Names:
KTB, CABO, FDUS, More
Financial Fact:
Research and development expense: 2.18B
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $2.77, $0.09 better than the analyst estimate of $2.68. Revenue for the quarter came in at $23.74 billion versus the consensus estimate of $22.86 billion.
GUIDANCE:
Johnson & Johnson sees FY2025 EPS of $10.63-$10.73, versus the consensus of $10.61. Johnson & Johnson sees FY2025 revenue of $93.2-93.6 billion, versus the consensus of $91.3 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ecovyst Inc. (ECVT) Tops Q3 EPS by 2c
- Progyny (PGNY) Tops Q3 EPS by 21c ; Offers Guidance
- UBS Upgrades Nuode New Materials Co Ltd (600110:CH) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
